Advertisement
In the recent clinical trials involving Chimeric Antigen Receptor T cell therapy (CAR-T), which complication led to a halt in the studies?
A. Myocardial infarction
B. Disseminated intravascular coagulation
C. Neurotoxicity
D. Systemic thrombosis
